drugset / Trial / NCT04468542

Randomized Placebo-controlled Analysis of Superior Laryngeal Nerve Block for Neurogenic Cough

NCT04468542

Phase 3 Unknown 65 enrolled University of South Florida
RandomizedParallel-groupSingle-blindTreatment

Summary

Prospective randomized placebo-controlled trial assessing the efficacy of superior laryngeal nerve block for adults with neurogenic cough refractory to proton pump inhibitor as determined by improvement in validated cough severity questionnaires before and after injection of Marcaine and Kenalog compared to placebo (saline injection).

Timeline

Start
2021-01-12
Primary completion
2022-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.5 % Other
Subject Triamcinolone Acetonide Other / unclassified 40 mg/ml Other

Indications

No indication recorded.